Integrating Acoustic Engineering, Sensing, Signal Processing and AI-Assisted Control
Datasea’s underlying acoustic capabilities include ultrasound generation, transmission, focusing and control; acoustic-energy delivery; sound and vibration sensing; acquisition of multi-source physiological signals; signal processing, feature recognition, parameter optimization and feedback control; and sensor integration, device control and hardware engineering.
Current commercialization priorities, plus directions in R&D / validation / pilot / early-stage commercialization
Reusable device-control and signal-flow orchestration modules
Core engineering capabilities across the acoustic signal chain
At the platform layer, building on its underlying sensor and hardware capabilities, Datasea uses control systems and software to package its underlying acoustic capabilities into reusable device-control and signal-flow orchestration modules, with product-specific adaptations for applicable safety standards, regulatory requirements and real-world use scenarios.
At the product and application layer, the Company’s current commercialization priorities are acoustic healthcare and acoustic medical applications. Acoustic healthcare has generated product and service revenue. In acoustic medical applications, Datasea is advancing NeuroVibe and related non-invasive biofeedback and brain-computer-interface technologies. Industrial acoustics, agricultural acoustics and acoustic IoT remain primarily in R&D, application validation, pilot deployment or early-stage commercialization and will be advanced selectively based on technical maturity, customer demand and expected commercial returns.
Current commercialization priority with product and service revenue across air, sleep, foot, head and personal care.
Products & services revenueCurrent priority: non-invasive biofeedback and brain-computer-interface technologies, advanced under the applicable regulatory framework.
NV-02 · NV-03 FDA establishment registration & device listingDatasea’s intellectual-property portfolio includes patents, patent applications, software copyrights, proprietary software, algorithms, product designs and technical know-how covering acoustic intelligence, biofeedback and brain-computer-interface applications, multimodal data processing, AI agents and related systems. During FY2026, the Company continued to expand this portfolio through internal development and acquisitions.
Covering acoustic intelligence, biofeedback and brain-computer-interface applications.
Proprietary software and software copyrights across platform and product systems.
Algorithms and product designs for acoustic and multimodal AI applications.
Know-how spanning device control, signal orchestration and AI-agent systems.